VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer

Incidents per State

State Total
92,076
AK1,880
AL6,345
AR4,151
AS46
AZ14,991
CA66,887
CO12,550
CT8,943
DC1,795
DE2,009
FL42,724
FM4
GA17,031
GU124
HI2,580
IA4,919
ID2,892
IL22,128
IN24,197
KS5,047
KY9,111
LA5,500
MA15,718
MD13,434
ME3,351
MH8
MI20,971
MN13,585
MO10,747
MP30
MS3,198
MT2,477
NC18,051
ND1,501
NE3,109
NH3,218
NJ20,216
NM4,218
NV4,728
NY37,667
OH20,793
OK6,692
OR9,244
PA25,607
PR2,588
QM2
RI2,163
SC7,261
SD1,282
TN10,445
TX39,890
UT4,618
VA15,980
VI67
VT1,830
WA16,071
WI12,042
WV2,571
WY926
XB5
XL1
XV2

ID: 1559946
Sex: F
Age: 62
State: GA

Vax Date: 02/26/2021
Onset Date: 02/26/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: whiplash; Injection site bruises; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (Injection site bruises) and POST-TRAUMATIC NECK SYNDROME (whiplash) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced VACCINATION SITE BRUISING (Injection site bruises). On an unknown date, the patient experienced POST-TRAUMATIC NECK SYNDROME (whiplash). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE BRUISING (Injection site bruises) and POST-TRAUMATIC NECK SYNDROME (whiplash) outcome was unknown.

Other Meds:

Current Illness:

ID: 1559947
Sex: F
Age:
State: SC

Vax Date: 02/11/2021
Onset Date: 02/14/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: diarrhea; chills; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea) and CHILLS (chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported.No relevant concomitant medications were reported. On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced DIARRHOEA (diarrhea) and CHILLS (chills). At the time of the report, DIARRHOEA (diarrhea) and CHILLS (chills) outcome was unknown. No treatment information was provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1559948
Sex: F
Age: 78
State: FL

Vax Date: 01/09/2021
Onset Date: 02/07/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: itchy rash 2 inches below the injection site; itchiness at injection site; felt unusually tired; This spontaneous case was reported by a patient and describes the occurrence of FATIGUE (felt unusually tired), VACCINATION SITE RASH (itchy rash 2 inches below the injection site) and VACCINATION SITE PRURITUS (itchiness at injection site) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 012L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Feb-2021, the patient experienced FATIGUE (felt unusually tired) and VACCINATION SITE PRURITUS (itchiness at injection site). On 08-Feb-2021, the patient experienced VACCINATION SITE RASH (itchy rash 2 inches below the injection site). On 08-Feb-2021, FATIGUE (felt unusually tired) had resolved. At the time of the report, VACCINATION SITE RASH (itchy rash 2 inches below the injection site) and VACCINATION SITE PRURITUS (itchiness at injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment information included acetaminophen for the unusual tiredness and Tylenol Concomitant medications were not provided.

Other Meds:

Current Illness:

ID: 1559949
Sex: M
Age:
State: CA

Vax Date: 02/28/2021
Onset Date: 02/28/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Shoulder pain ( L arm, injection site); The first night he couldn't sleep; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (The first night he couldn't sleep) and VACCINATION SITE PAIN (Shoulder pain ( L arm, injection site)) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 28-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Feb-2021, the patient experienced INSOMNIA (The first night he couldn't sleep). On an unknown date, the patient experienced VACCINATION SITE PAIN (Shoulder pain ( L arm, injection site)). At the time of the report, INSOMNIA (The first night he couldn't sleep) and VACCINATION SITE PAIN (Shoulder pain ( L arm, injection site)) outcome was unknown. Concomitant information was Type 2 diabetes medicine. Treatment information was not provided This case was linked to MOD-2021-032275 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Follow up received and contain non significant information.

Other Meds:

Current Illness:

ID: 1559950
Sex: F
Age: 56
State: NC

Vax Date: 02/25/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: itchy/dry throat; Feverish; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of THROAT IRRITATION (itchy/dry throat) and PYREXIA (Feverish) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. Concomitant products included Anti Depressant and Cholesterol Medication for an unknown indication. On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced THROAT IRRITATION (itchy/dry throat) and PYREXIA (Feverish). At the time of the report, THROAT IRRITATION (itchy/dry throat) and PYREXIA (Feverish) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: Anti Depressant; Cholesterol Medication

Current Illness:

ID: 1559951
Sex: F
Age:
State: FL

Vax Date: 02/02/2021
Onset Date: 02/02/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: red circle the size of a "half dollar"; it itches like crazy; soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness), VACCINATION SITE ERYTHEMA (red circle the size of a "half dollar") and VACCINATION SITE PRURITUS (it itches like crazy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced VACCINATION SITE PAIN (soreness). On 10-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (red circle the size of a "half dollar") and VACCINATION SITE PRURITUS (it itches like crazy). At the time of the report, VACCINATION SITE PAIN (soreness), VACCINATION SITE ERYTHEMA (red circle the size of a "half dollar") and VACCINATION SITE PRURITUS (it itches like crazy) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1559952
Sex: F
Age:
State: LA

Vax Date: 03/01/2021
Onset Date: 03/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: "really bad rash" at the injection site; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of INJECTION SITE RASH ("really bad rash" at the injection site) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 01-Mar-2021, the patient experienced INJECTION SITE RASH ("really bad rash" at the injection site). At the time of the report, INJECTION SITE RASH ("really bad rash" at the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant information use was not reported. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1559953
Sex: F
Age: 70
State: KY

Vax Date: 02/02/2021
Onset Date: 03/01/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: appetite decreased, very unusual; very little soreness around the area of injection; not motivated to do anything; temperature 96.6?F (usually little lower); This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (appetite decreased, very unusual), VACCINATION SITE PAIN (very little soreness around the area of injection), FATIGUE (not motivated to do anything) and PYREXIA (temperature 96.6?F (usually little lower)) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 016M20A) for COVID-19 vaccination. Concomitant products included VITAMIN D NOS, CALCIUM and MULTIVITAMIN & MINERAL for an unknown indication. On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 01-Mar-2021, the patient experienced PYREXIA (temperature 96.6?F (usually little lower)). On an unknown date, the patient experienced DECREASED APPETITE (appetite decreased, very unusual), VACCINATION SITE PAIN (very little soreness around the area of injection) and FATIGUE (not motivated to do anything). At the time of the report, DECREASED APPETITE (appetite decreased, very unusual), VACCINATION SITE PAIN (very little soreness around the area of injection), FATIGUE (not motivated to do anything) and PYREXIA (temperature 96.6?F (usually little lower)) outcome was unknown.

Other Meds: VITAMIN D NOS; CALCIUM; MULTIVITAMIN & MINERAL

Current Illness:

ID: 1559954
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: arm was red; sore arm; itchy; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (arm was red), PAIN IN EXTREMITY (sore arm) and PRURITUS (itchy) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (arm was red), PAIN IN EXTREMITY (sore arm) and PRURITUS (itchy). At the time of the report, ERYTHEMA (arm was red), PAIN IN EXTREMITY (sore arm) and PRURITUS (itchy) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1559955
Sex: F
Age: 66
State: MD

Vax Date: 02/20/2021
Onset Date: 02/20/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: sleepiness; Fatigue that comes and goes; This spontaneous case was reported by a physician and describes the occurrence of SOMNOLENCE (sleepiness) and FATIGUE (Fatigue that comes and goes) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. No Medical history was reported. Concomitant products included LORATADINE for Allergy, ALPRAZOLAM for Sleep problem, PANTOPRAZOLE and ESCITALOPRAM for an unknown indication. On 20-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced FATIGUE (Fatigue that comes and goes). On an unknown date, the patient experienced SOMNOLENCE (sleepiness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, SOMNOLENCE (sleepiness) and FATIGUE (Fatigue that comes and goes) was resolving. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. The patient reported fatigue has come back in full force. It is Friday, Saturday, Sunday, today (understood as 01-Mar-2021) she was feeling a little better.

Other Meds: LORATADINE; PANTOPRAZOLE; ALPRAZOLAM; ESCITALOPRAM

Current Illness:

ID: 1559956
Sex: F
Age:
State: TX

Vax Date: 01/22/2021
Onset Date: 02/03/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: think it's shingles; I saw couple of spot under my breast, did not think its shingles but than saw NP on; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (I saw couple of spot under my breast, did not think its shingles but than saw NP on) and HERPES ZOSTER (think it's shingles) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID], ATORVASTATIN, METOPROLOL SUCCINATE, FAMOTIDINE (PEPCID [FAMOTIDINE]) and PROPAFENONE for an unknown indication. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced ADVERSE REACTION (I saw couple of spot under my breast, did not think its shingles but than saw NP on). On 08-Feb-2021, the patient experienced HERPES ZOSTER (think it's shingles). The patient was treated with BACITRACIN, NEOMYCIN SULFATE, POLYMYXIN B SULFATE (NEOSPORIN [BACITRACIN;NEOMYCIN SULFATE;POLYMYXIN B SULFATE]) at an unspecified dose and frequency and VALACYCLOVIR [VALACICLOVIR] at an unspecified dose and frequency. At the time of the report, ADVERSE REACTION (I saw couple of spot under my breast, did not think its shingles but than saw NP on) and HERPES ZOSTER (think it's shingles) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: ASPIRIN [ACETYLSALICYLIC ACID]; ATORVASTATIN; METOPROLOL SUCCINATE; PEPCID [FAMOTIDINE]; PROPAFENONE

Current Illness:

ID: 1559957
Sex: F
Age:
State:

Vax Date: 02/26/2021
Onset Date: 02/26/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: nervous; Feeling nauseous; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of NERVOUSNESS (nervous) and NAUSEA (Feeling nauseous) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced NERVOUSNESS (nervous) and NAUSEA (Feeling nauseous). At the time of the report, NERVOUSNESS (nervous) and NAUSEA (Feeling nauseous) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1559958
Sex: F
Age: 79
State: OH

Vax Date: 01/22/2021
Onset Date: 02/25/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: cough; runny nose; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough) and RHINORRHOEA (runny nose) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced COUGH (cough) and RHINORRHOEA (runny nose). At the time of the report, COUGH (cough) and RHINORRHOEA (runny nose) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1559959
Sex: F
Age: 87
State: NJ

Vax Date: 02/26/2021
Onset Date: 02/26/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Site of injection is red and swollen; site of injection become blue and black; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 02-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Site of injection is red and swollen) and VACCINATION SITE DISCOLOURATION (site of injection become blue and black) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. No Medical History information was reported. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced VACCINATION SITE SWELLING (Site of injection is red and swollen) and VACCINATION SITE DISCOLOURATION (site of injection become blue and black). At the time of the report, VACCINATION SITE SWELLING (Site of injection is red and swollen) and VACCINATION SITE DISCOLOURATION (site of injection become blue and black) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds:

Current Illness:

ID: 1559960
Sex: F
Age:
State:

Vax Date: 02/26/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: loss of taste; weakness; soreness; fever; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of AGEUSIA (loss of taste), ASTHENIA (weakness), PAIN (soreness) and PYREXIA (fever) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced AGEUSIA (loss of taste), ASTHENIA (weakness), PAIN (soreness) and PYREXIA (fever). At the time of the report, AGEUSIA (loss of taste), ASTHENIA (weakness), PAIN (soreness) and PYREXIA (fever) outcome was unknown. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1559961
Sex: F
Age:
State: OH

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Redness; Itchiness; Rash; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Redness), PRURITUS (Itchiness) and RASH (Rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Redness), PRURITUS (Itchiness) and RASH (Rash). At the time of the report, ERYTHEMA (Redness), PRURITUS (Itchiness) and RASH (Rash) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication was reported No treatment medication was reported Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: Reporter details updated, patient details updated

Other Meds:

Current Illness:

ID: 1559962
Sex: F
Age:
State: MN

Vax Date: 01/29/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: flu-like symptoms such as cough but no fever; flu-like symptoms such as cough but no fever; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms such as cough but no fever) and COUGH (flu-like symptoms such as cough but no fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010m20a) for COVID-19 vaccination. No Medical History information was reported. On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms such as cough but no fever) and COUGH (flu-like symptoms such as cough but no fever). At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms such as cough but no fever) and COUGH (flu-like symptoms such as cough but no fever) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant information use was not reported. Treatment information was not provided.

Other Meds:

Current Illness:

ID: 1559963
Sex: F
Age:
State:

Vax Date: 02/25/2021
Onset Date: 02/25/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Had to stay in bed all day; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Had to stay in bed all day) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced ASTHENIA (Had to stay in bed all day). On 26-Feb-2021, ASTHENIA (Had to stay in bed all day) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1559964
Sex: F
Age: 73
State: WI

Vax Date: 02/27/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: swollen arm; dizziness; body aches; major headaches; fever; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen arm), DIZZINESS (dizziness), PAIN (body aches), HEADACHE (major headaches) and PYREXIA (fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. No Medical History information was reported. On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (swollen arm), DIZZINESS (dizziness), PAIN (body aches), HEADACHE (major headaches) and PYREXIA (fever). At the time of the report, PERIPHERAL SWELLING (swollen arm), DIZZINESS (dizziness), PAIN (body aches), HEADACHE (major headaches) and PYREXIA (fever) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.

Other Meds:

Current Illness:

ID: 1559965
Sex: F
Age:
State: MD

Vax Date: 02/26/2021
Onset Date: 02/26/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Felt like she could not move her arm; Had no power in her arms and could hardly hold a teacup; Started feeling funny; Was frightened; Not much of an appetite and did not want to eat; Not feeling 100%; Had chills; The shot was very painful and she felt like it was going to go through her arm; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Felt like she could not move her arm), MUSCULAR WEAKNESS (Had no power in her arms and could hardly hold a teacup), INAPPROPRIATE AFFECT (Started feeling funny), FEAR (Was frightened) and DECREASED APPETITE (Not much of an appetite and did not want to eat) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (Felt like she could not move her arm), MUSCULAR WEAKNESS (Had no power in her arms and could hardly hold a teacup), INAPPROPRIATE AFFECT (Started feeling funny), FEAR (Was frightened), DECREASED APPETITE (Not much of an appetite and did not want to eat), FEELING ABNORMAL (Not feeling 100%), CHILLS (Had chills) and VACCINATION SITE PAIN (The shot was very painful and she felt like it was going to go through her arm). On 26-Feb-2021, PAIN IN EXTREMITY (Felt like she could not move her arm), MUSCULAR WEAKNESS (Had no power in her arms and could hardly hold a teacup), INAPPROPRIATE AFFECT (Started feeling funny), FEAR (Was frightened), DECREASED APPETITE (Not much of an appetite and did not want to eat), FEELING ABNORMAL (Not feeling 100%), CHILLS (Had chills) and VACCINATION SITE PAIN (The shot was very painful and she felt like it was going to go through her arm) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1559966
Sex: F
Age: 78
State: CA

Vax Date: 01/26/2021
Onset Date: 02/27/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: injection site itching; Site of injection has red mark; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (injection site itching) and VACCINATION SITE ERYTHEMA (Site of injection has red mark) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042L20A and 024M20A) for COVID-19 vaccination. No Medical History information was reported. On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (injection site itching) and VACCINATION SITE ERYTHEMA (Site of injection has red mark). At the time of the report, VACCINATION SITE PRURITUS (injection site itching) and VACCINATION SITE ERYTHEMA (Site of injection has red mark) outcome was unknown. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1559967
Sex: F
Age: 68
State: MA

Vax Date: 02/24/2021
Onset Date: 02/24/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Pain on her left breast down near her armpit, which spread around her breast; Arm hurt for 24 hours; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm hurt for 24 hours) and BREAST PAIN (Pain on her left breast down near her armpit, which spread around her breast) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. No Medical History information was reported. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm hurt for 24 hours). On an unknown date, the patient experienced BREAST PAIN (Pain on her left breast down near her armpit, which spread around her breast). On 25-Feb-2021, PAIN IN EXTREMITY (Arm hurt for 24 hours) had resolved. At the time of the report, BREAST PAIN (Pain on her left breast down near her armpit, which spread around her breast) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1559968
Sex: F
Age: 77
State: NJ

Vax Date: 02/04/2021
Onset Date: 02/06/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: lip swelling; Facial swelling made me look like a chipmunk; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (lip swelling) and SWELLING FACE (Facial swelling made me look like a chipmunk) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. No Medical History information was reported. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, the patient experienced LIP SWELLING (lip swelling) and SWELLING FACE (Facial swelling made me look like a chipmunk). On 08-Feb-2021, LIP SWELLING (lip swelling) and SWELLING FACE (Facial swelling made me look like a chipmunk) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No Concomitant medications and No Treatment medications were reported. Patient states no derma fillers taken. Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Updated Reporter details[Address, Email and Fax].

Other Meds:

Current Illness:

ID: 1559969
Sex: F
Age: 77
State: MO

Vax Date: 02/09/2021
Onset Date: 02/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Soreness at the injection site/at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness at the injection site/at the injection site) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation. No Medical History information was reported. On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced VACCINATION SITE PAIN (Soreness at the injection site/at the injection site). At the time of the report, VACCINATION SITE PAIN (Soreness at the injection site/at the injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1559970
Sex: M
Age: 76
State: MN

Vax Date: 02/19/2021
Onset Date: 02/19/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Felt tired for one day; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Felt tired for one day) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 24M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concomitant products included FINASTERIDE, DULOXETINE, HYDROCHLOROTHIAZIDE, LISINOPRIL (LISINOPRIL HCTZ) and AMLODIPINE for an unknown indication. On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced FATIGUE (Felt tired for one day). At the time of the report, FATIGUE (Felt tired for one day) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.

Other Meds: FINASTERIDE; DULOXETINE; LISINOPRIL HCTZ; AMLODIPINE

Current Illness:

ID: 1559971
Sex: M
Age: 74
State: NJ

Vax Date: 01/28/2021
Onset Date: 01/28/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Allergic reaction rash; rash on both legs and on inside of both his fore arms; arm hurt for a few days; This spontaneous case was reported by a consumer and describes the occurrence of ALLERGY TO VACCINE (Allergic reaction rash), PAIN IN EXTREMITY (arm hurt for a few days) and RASH (rash on both legs and on inside of both his fore arms) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 001A121A) for COVID-19 vaccination. The patient's past medical history included Enlarged prostate. Concurrent medical conditions included Hypertension on 01-Jan-1999 and Asthma on 01-Mar-2019. Concomitant products included MOMETASONE FUROATE (ASMANEX) from 01-Mar-2019 to an unknown date for Asthma, ATORVASTATIN from 01-Jan-2000 to an unknown date for Blood cholesterol, FINASTERIDE from 21-Jan-2016 to an unknown date for Prostatomegaly, TAMSULOSIN from 21-Jan-2016 to an unknown date for an unknown indication. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm hurt for a few days). On 01-Feb-2021, the patient experienced RASH (rash on both legs and on inside of both his fore arms). On an unknown date, the patient experienced ALLERGY TO VACCINE (Allergic reaction rash). On 12-Feb-2021, ALLERGY TO VACCINE (Allergic reaction rash) and RASH (rash on both legs and on inside of both his fore arms) had resolved. At the time of the report, PAIN IN EXTREMITY (arm hurt for a few days) outcome was unknown. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment included Benadryl, Hydrocortisone cream, Clear Caladril Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: additional reporter information, medical history, concomitant medication ,second dose information, was added and outcome of the event was changed from unknown to resolved

Other Meds: ATORVASTATIN; ASMANEX; TAMSULOSIN; FINASTERIDE

Current Illness:

ID: 1559972
Sex: F
Age: 40
State: NM

Vax Date: 02/04/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: arm felt numb; arm hard to move due to pain; swollen arm; tender arm; arm hard under injection site; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (arm felt numb), PAIN IN EXTREMITY (arm hard to move due to pain), PERIPHERAL SWELLING (swollen arm), TENDERNESS (tender arm) and VACCINATION SITE INDURATION (arm hard under injection site) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. No Medical History information was reported. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (arm felt numb), PAIN IN EXTREMITY (arm hard to move due to pain), PERIPHERAL SWELLING (swollen arm), TENDERNESS (tender arm) and VACCINATION SITE INDURATION (arm hard under injection site). At the time of the report, HYPOAESTHESIA (arm felt numb), PAIN IN EXTREMITY (arm hard to move due to pain), PERIPHERAL SWELLING (swollen arm), TENDERNESS (tender arm) and VACCINATION SITE INDURATION (arm hard under injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1559973
Sex: F
Age: 59
State: MI

Vax Date: 02/26/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Stiffness over the body plus injection arm; slept for 12 straight on Friday; slept for 24 hours on Saturday; getting a little now except for sleepiness; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Stiffness over the body plus injection arm), SLEEP DISORDER (slept for 12 straight on Friday), HYPERSOMNIA (slept for 24 hours on Saturday) and SOMNOLENCE (getting a little now except for sleepiness) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination. No Medical History information was reported. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (Stiffness over the body plus injection arm), SLEEP DISORDER (slept for 12 straight on Friday), HYPERSOMNIA (slept for 24 hours on Saturday) and SOMNOLENCE (getting a little now except for sleepiness). At the time of the report, MUSCULOSKELETAL STIFFNESS (Stiffness over the body plus injection arm) was resolving and SLEEP DISORDER (slept for 12 straight on Friday), HYPERSOMNIA (slept for 24 hours on Saturday) and SOMNOLENCE (getting a little now except for sleepiness) outcome was unknown. Patient stated that The second vaccine was not as bad as the first. No concomitant medications were provided by the reporter. No treatment information was provided. This case was linked to MOD-2021-264281 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Additional information was received on 22-JUL-2021 contains patient's demographics (gender and initials) and dose 2 information.

Other Meds:

Current Illness:

ID: 1559974
Sex: F
Age: 59
State: PA

Vax Date: 02/26/2021
Onset Date: 02/26/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Face became numb; Lips began to swell; Her bottom lips was burning; Throat was scratchy; Ice tea burn as it was going down; Coughing; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Face became numb), LIP SWELLING (Lips began to swell), ORAL DISCOMFORT (Her bottom lips was burning), OROPHARYNGEAL DISCOMFORT (Throat was scratchy) and ORAL DISCOMFORT (Ice tea burn as it was going down) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001AZIA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Asthma and Shellfish allergy. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced HYPOAESTHESIA (Face became numb), LIP SWELLING (Lips began to swell), ORAL DISCOMFORT (Her bottom lips was burning), OROPHARYNGEAL DISCOMFORT (Throat was scratchy), ORAL DISCOMFORT (Ice tea burn as it was going down) and COUGH (Coughing). At the time of the report, HYPOAESTHESIA (Face became numb), LIP SWELLING (Lips began to swell), ORAL DISCOMFORT (Her bottom lips was burning), OROPHARYNGEAL DISCOMFORT (Throat was scratchy), ORAL DISCOMFORT (Ice tea burn as it was going down) and COUGH (Coughing) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Reporter did not allow further contact

Other Meds:

Current Illness: Asthma; Shellfish allergy

ID: 1559975
Sex: F
Age:
State: NC

Vax Date: 02/25/2021
Onset Date: 02/25/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: pretty bad Pressure in her chest; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (pretty bad Pressure in her chest) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 14M20A) for COVID-19 vaccination. Concurrent medical conditions included Blood pressure high, Asthma, Diabetes and Allergy. On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced CHEST DISCOMFORT (pretty bad Pressure in her chest). At the time of the report, CHEST DISCOMFORT (pretty bad Pressure in her chest) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant medications blood pressure medications, asthma medications, sugar shots and allergy medicine. Treatment information was not provided. Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Updated re-challenge field.

Other Meds:

Current Illness: Allergy; Asthma; Blood pressure high; Diabetes

ID: 1559976
Sex: M
Age: 80
State: PA

Vax Date: 02/27/2021
Onset Date: 02/27/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Sneezing; Runny nose; Dry cough; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of SNEEZING (Sneezing), RHINORRHOEA (Runny nose) and COUGH (Dry cough) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. No Medical History information was reported. On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced SNEEZING (Sneezing), RHINORRHOEA (Runny nose) and COUGH (Dry cough). At the time of the report, SNEEZING (Sneezing), RHINORRHOEA (Runny nose) and COUGH (Dry cough) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. This case was linked to MOD-2021-029896 (E2B Linked Report).; Sender's Comments: MOD-2021-029896:

Other Meds:

Current Illness:

ID: 1559977
Sex: F
Age:
State: NY

Vax Date: 03/01/2021
Onset Date: 02/28/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: face freezing; something is wrong; Face numbness and tingling; left arm numbness; neck numbness; lips numbness; eyes numbness; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (face freezing), DISCOMFORT (something is wrong), HYPOAESTHESIA (Face numbness and tingling), HYPOAESTHESIA (left arm numbness) and HYPOAESTHESIA (neck numbness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unk) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced FEELING COLD (face freezing), DISCOMFORT (something is wrong), HYPOAESTHESIA (Face numbness and tingling), HYPOAESTHESIA (left arm numbness), HYPOAESTHESIA (neck numbness), HYPOAESTHESIA ORAL (lips numbness) and HYPOAESTHESIA EYE (eyes numbness). At the time of the report, FEELING COLD (face freezing), DISCOMFORT (something is wrong), HYPOAESTHESIA (Face numbness and tingling), HYPOAESTHESIA (left arm numbness), HYPOAESTHESIA (neck numbness), HYPOAESTHESIA ORAL (lips numbness) and HYPOAESTHESIA EYE (eyes numbness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1559978
Sex: F
Age: 71
State: FL

Vax Date: 02/02/2021
Onset Date: 02/02/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: fatigue; headache; body aches; chills; violently sick; like covid again; smells exhaust fumes; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (violently sick), SYMPTOM RECURRENCE (like covid again), PAROSMIA (smells exhaust fumes), FATIGUE (fatigue) and HEADACHE (headache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19. Concomitant products included GABAPENTIN and CLOZAPINE for an unknown indication. On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced PAROSMIA (smells exhaust fumes). On 03-Feb-2021, the patient experienced ILLNESS (violently sick), SYMPTOM RECURRENCE (like covid again), FATIGUE (fatigue), HEADACHE (headache), MYALGIA (body aches) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 07-Feb-2021, ILLNESS (violently sick), SYMPTOM RECURRENCE (like covid again), HEADACHE (headache), MYALGIA (body aches) and CHILLS (chills) had resolved. At the time of the report, PAROSMIA (smells exhaust fumes) outcome was unknown and FATIGUE (fatigue) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: GABAPENTIN; CLOZAPINE

Current Illness:

ID: 1559979
Sex: M
Age: 79
State: FL

Vax Date: 02/24/2021
Onset Date: 02/24/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Throat closing; Joint pain in shoulder; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of THROAT TIGHTNESS (Throat closing) and ARTHRALGIA (Joint pain in shoulder) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Multiple myeloma. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced THROAT TIGHTNESS (Throat closing) and ARTHRALGIA (Joint pain in shoulder). On 24-Feb-2021, THROAT TIGHTNESS (Throat closing) had resolved. On 27-Feb-2021, ARTHRALGIA (Joint pain in shoulder) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds:

Current Illness: Multiple myeloma

ID: 1559980
Sex: M
Age: 75
State: MI

Vax Date: 02/04/2021
Onset Date: 02/14/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Allergic dermatitis; Rash all over his body (looks like the rash people get from having COVID-19); This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 01-Mar-2021 and was forwarded to Moderna on 01-Mar-2021. This spontaneous case was reported by a consumer and describes the occurrence of DERMATITIS ALLERGIC (Allergic dermatitis) and RASH (Rash all over his body (looks like the rash people get from having COVID-19)) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L204) for COVID-19 vaccination. Concurrent medical conditions included Diabetes mellitus. Concomitant products included INSULIN HUMAN, INSULIN HUMAN INJECTION, ISOPHANE (NOVOLIN 30/70), GLIPIZIDE, ATORVASTATIN, CALCIUM and ALLOPURINOL for an unknown indication. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Feb-2021, the patient experienced RASH (Rash all over his body (looks like the rash people get from having COVID-19)). On an unknown date, the patient experienced DERMATITIS ALLERGIC (Allergic dermatitis). At the time of the report, DERMATITIS ALLERGIC (Allergic dermatitis) and RASH (Rash all over his body (looks like the rash people get from having COVID-19)) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds: NOVOLIN 30/70; GLIPIZIDE; ATORVASTATIN; CALCIUM; ALLOPURINOL

Current Illness: Diabetes mellitus

ID: 1559981
Sex: F
Age: 71
State: NC

Vax Date: 02/24/2021
Onset Date: 02/24/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Face feels hot; Dizzy; Upset stomach; No appetite; Headache; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Face feels hot), DIZZINESS (Dizzy), ABDOMINAL DISCOMFORT (Upset stomach), DECREASED APPETITE (No appetite) and HEADACHE (Headache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. Concurrent medical conditions included Lung cancer and Breast cancer. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced FEELING HOT (Face feels hot), DIZZINESS (Dizzy), ABDOMINAL DISCOMFORT (Upset stomach), DECREASED APPETITE (No appetite) and HEADACHE (Headache). At the time of the report, FEELING HOT (Face feels hot), DIZZINESS (Dizzy), ABDOMINAL DISCOMFORT (Upset stomach), DECREASED APPETITE (No appetite) and HEADACHE (Headache) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. Treatment medication included Tylenol (paracetamol) and taking Tylenol was helping somewhat.

Other Meds:

Current Illness: Breast cancer; Lung cancer

ID: 1559982
Sex: F
Age:
State: CA

Vax Date: 01/13/2021
Onset Date: 02/08/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Root canal; This spontaneous case was reported by a consumer and describes the occurrence of ENDODONTIC PROCEDURE (Root canal) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. No Medical History information was reported. On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced ENDODONTIC PROCEDURE (Root canal). The patient was treated with AMOXICILLIN at an unspecified dose and frequency. On 08-Feb-2021, ENDODONTIC PROCEDURE (Root canal) had resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter.

Other Meds:

Current Illness:

ID: 1559983
Sex: F
Age: 75
State: CA

Vax Date: 02/04/2021
Onset Date: 02/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: visual disturbances/saw "a small elongated triangle that was orange in color"/saw "a small elongated triangle that was blue in color"; This spontaneous case was reported by a consumer and describes the occurrence of VISUAL IMPAIRMENT (visual disturbances/saw "a small elongated triangle that was orange in color"/saw "a small elongated triangle that was blue in color") in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. Concurrent medical conditions included Macular degeneration ((wet, dry)), Arthritis, Asthma, Coronary artery disease, Diverticulosis, Barrett's esophagus (Barrett's esophagus III), GERD and Glaucoma (Suspected glaucoma). Concomitant products included MONTELUKAST SODIUM (SINGULAIR), AMLODIPINE BESILATE (NORVASC), EZETIMIBE (ZETIA), CELECOXIB (CELEBREX), DEXLANSOPRAZOLE (DEXILANT), ROSUVASTATIN CALCIUM (CRESTOR), FAMOTIDINE (PEPCID [FAMOTIDINE]), ASCORBIC ACID, CUPRIC OXIDE, DL-ALPHA TOCOPHERYL ACETATE, XANTOFYL, ZEAXANTHIN, ZINC OXIDE (PRESERVISION AREDS 2), FISH OIL, UBIDECARENONE (CO Q-10), THIAMINE HYDROCHLORIDE (VITAMIN B-6), THIAMINE HYDROCHLORIDE (VITAMIN B-12), BRIMONIDINE TARTRATE, BRINZOLAMIDE (SIMBRINZA), DICLOFENAC (VOLTAREN [DICLOFENAC]), RANIBIZUMAB (LUCENTIS) and FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR) for an unknown indication. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced VISUAL IMPAIRMENT (visual disturbances/saw "a small elongated triangle that was orange in color"/saw "a small elongated triangle that was blue in color"). On 09-Feb-2021, VISUAL IMPAIRMENT (visual disturbances/saw "a small elongated triangle that was orange in color"/saw "a small elongated triangle that was blue in color") had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was reported.

Other Meds: SINGULAIR; NORVASC; ZETIA; CELEBREX; DEXILANT; CRESTOR; PEPCID [FAMOTIDINE]; PRESERVISION AREDS 2; FISH OIL; CO Q-10; VITAMIN B-6; VITAMIN B-12; SIMBRINZA; VOLTAREN [DICLOFENAC]; LUCENTIS; ADVAIR

Current Illness:

ID: 1559984
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: arm was itchy; arm was warm to the touch; Aching arm; arm was red from her shoulder to her elbow; bit sore at injection site; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (arm was itchy), FEELING HOT (arm was warm to the touch), PAIN IN EXTREMITY (Aching arm), ERYTHEMA (arm was red from her shoulder to her elbow) and VACCINATION SITE PAIN (bit sore at injection site) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Sulfonamide allergy and Drug allergy (Dilaudid, her throat started to close (post-surgery for hip replacement).). On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (arm was itchy), FEELING HOT (arm was warm to the touch), PAIN IN EXTREMITY (Aching arm), ERYTHEMA (arm was red from her shoulder to her elbow) and VACCINATION SITE PAIN (bit sore at injection site). At the time of the report, PRURITUS (arm was itchy), FEELING HOT (arm was warm to the touch) and PAIN IN EXTREMITY (Aching arm) outcome was unknown and ERYTHEMA (arm was red from her shoulder to her elbow) and VACCINATION SITE PAIN (bit sore at injection site) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. Concomitant product use was not provided by the reporter. Patients doctor immediately put her on an antibiotic in case of cellulitis

Other Meds:

Current Illness: Drug allergy (Dilaudid, her throat started to close (post-surgery for hip replacement).); Sulfonamide allergy

ID: 1559985
Sex: F
Age: 85
State: MD

Vax Date: 02/05/2021
Onset Date: 02/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Covid exposure after 1 dose; This spontaneous case was reported by a consumer and describes the occurrence of EXPOSURE TO SARS-COV-2 (Covid exposure after 1 dose) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025S20A) for COVID-19 vaccination. Concomitant products included LORAZEPAM from 05-Feb-2021 to an unknown date for an unknown indication. On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced EXPOSURE TO SARS-COV-2 (Covid exposure after 1 dose). At the time of the report, EXPOSURE TO SARS-COV-2 (Covid exposure after 1 dose) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was provided. Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Follow up received on 21-JUL-2021 contains: Updated contact details- Email ID;

Other Meds: LORAZEPAM

Current Illness:

ID: 1559986
Sex: F
Age: 75
State: GA

Vax Date: 02/08/2021
Onset Date: 02/08/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Post nasal drip sore throat; Muscle pain; Tired and Exhausted; Fever; Headache; Chills; Feeling sick; Lethargic; Sore throat; Running nose; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Feeling sick), LETHARGY (Lethargic), OROPHARYNGEAL PAIN (Sore throat), RHINORRHOEA (Running nose) and UPPER-AIRWAY COUGH SYNDROME (Post nasal drip sore throat) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Allergy. Concomitant products included IBUPROFEN (ADVIL [IBUPROFEN]), LOSARTAN, AMLODIPINE, ATORVASTATIN, ACETYLSALICYLIC ACID (BABY ASPIRIN), LEVOCETIRIZINE, ESCITALOPRAM OXALATE (LEXAPRO) and LAMOTRIGINE for an unknown indication. On 08-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced MALAISE (Feeling sick), LETHARGY (Lethargic), OROPHARYNGEAL PAIN (Sore throat), RHINORRHOEA (Running nose), MYALGIA (Muscle pain), FATIGUE (Tired and Exhausted), PYREXIA (Fever), HEADACHE (Headache) and CHILLS (Chills). On 10-Feb-2021, the patient experienced UPPER-AIRWAY COUGH SYNDROME (Post nasal drip sore throat). At the time of the report, MALAISE (Feeling sick), LETHARGY (Lethargic), OROPHARYNGEAL PAIN (Sore throat), RHINORRHOEA (Running nose), MYALGIA (Muscle pain), FATIGUE (Tired and Exhausted), PYREXIA (Fever), HEADACHE (Headache) and CHILLS (Chills) was resolving and UPPER-AIRWAY COUGH SYNDROME (Post nasal drip sore throat) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Feb-2021, Body temperature: 100.7 (High) degree Fahrenheit. No treatment information was provided.

Other Meds: ADVIL [IBUPROFEN]; LOSARTAN; AMLODIPINE; ATORVASTATIN; BABY ASPIRIN; LEVOCETIRIZINE; LEXAPRO; LAMOTRIGINE

Current Illness: Allergy

ID: 1559987
Sex: F
Age: 36
State: NJ

Vax Date: 02/24/2021
Onset Date: 02/24/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: hands and feet are beet red; hands and feet are swollen; not been able to sleep; severe sunburn that is very very painful and feels like she is on fire; severe sunburn that is very very painful and feels like she is on fire; severe sunburn that is very very painful and feels like she is on fire; rash hot and burning; big red rash on back that spread over entire body / rash on the back/ rash all over from stomach to legs/rash on arms/rash on chest; extremely exhausted; nervous; pain at the injection site; red at injection site; chills; shakiness /feels like has the shakes; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ERYTHEMA (hands and feet are beet red), PERIPHERAL SWELLING (hands and feet are swollen), INSOMNIA (not been able to sleep), PAIN OF SKIN (severe sunburn that is very very painful and feels like she is on fire) and SUNBURN (severe sunburn that is very very painful and feels like she is on fire) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (red at injection site). On an unknown date, the patient experienced ERYTHEMA (hands and feet are beet red), PERIPHERAL SWELLING (hands and feet are swollen), INSOMNIA (not been able to sleep), PAIN OF SKIN (severe sunburn that is very very painful and feels like she is on fire), SUNBURN (severe sunburn that is very very painful and feels like she is on fire) and SKIN BURNING SENSATION (severe sunburn that is very very painful and feels like she is on fire). The patient was treated with ALUMINIUM HYDROXIDE, MAGNESIUM TRISILICATE, SODIUM ALGINATE (PEPCID [ALUMINIUM HYDROXIDE;MAGNESIUM TRISILICATE;SODIUM ALGINATE]) for Adverse event, at an unspecified dose and frequency; CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for Adverse event, at an unspecified dose and frequency and LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) for Adverse event, at an unspecified dose and frequency. At the time of the report, ERYTHEMA (hands and feet are beet red), PERIPHERAL SWELLING (hands and feet are swollen), INSOMNIA (not been able to sleep), PAIN OF SKIN (severe sunburn that is very very painful and feels like she is on fire), SUNBURN (severe sunburn that is very very painful and feels like she is on fire), SKIN BURNING SENSATION (severe sunburn that is very very painful and feels like she is on fire) and VACCINATION SITE ERYTHEMA (red at injection site) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 12-Mar-2021: No specific follow-up information recorded.

Other Meds:

Current Illness:

ID: 1559988
Sex: F
Age: 87
State: CT

Vax Date: 01/25/2021
Onset Date: 02/02/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Not well; Big red circle around injection site/affected area 2.5 inches on arm/could see hole in arm; 2nd dose scheduled 45 days after the first dose; A spontaneous report was received from an 87-year-old female patient concerning herself who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced events of not well, big red circle around injection site/affected area 2.5 inches on arm/could see hole in arm, and the 2nd dose scheduled 45 days after the first dose. The patient's medical history was not provided. No relevant concomitant medications were reported. On 25 Jan 2021, 4 days prior to the onset of events, the patient received the first of two planned doses of mRNA-1273 (Batch number: 029L20A) intramuscularly in left arm for prophylaxis of COVID-19 infection. The 2nd dose was scheduled 45 days after the first dose. On an unknown date, the patient was not well. On an unknown date, the patient experienced big red circle around injection site. The affected area was 2.5 inches on arm. The patient stated could see hole in arm. It lasted for 6 days and went away. The patient did not take any treatment, went away on own. Action taken with mRNA-1273 in response to the events was unknown. The event of 2nd dose scheduled 45 days after the first dose was considered resolved, while the outcome of the events of not well, big red circle around injection site/affected area 2.5 inches on arm/could see hole in arm was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1559989
Sex: F
Age:
State: FL

Vax Date: 02/26/2021
Onset Date: 02/26/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: Developed low grade fever, of 99.5 that still persists; Sore arm, nothing major; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm, nothing major) and PYREXIA (Developed low grade fever, of 99.5 that still persists) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 26-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm, nothing major). On 01-Mar-2021, the patient experienced PYREXIA (Developed low grade fever, of 99.5 that still persists). At the time of the report, PAIN IN EXTREMITY (Sore arm, nothing major) outcome was unknown and PYREXIA (Developed low grade fever, of 99.5 that still persists) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Mar-2021, Body temperature: 99.5 (High) Fever. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1559990
Sex: F
Age: 52
State: FL

Vax Date: 02/26/2021
Onset Date: 02/26/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: Face was flushed; tingling in her cheeks, lips, and tongue - "that feeling you get when you apply those lip pumping lipsticks."; numbness in her cheeks, lips, and tongue - "that feeling you get when you apply those lip pumping lipsticks."; This spontaneous case was reported by a nurse and describes the occurrence of FLUSHING (Face was flushed), PARAESTHESIA ORAL (tingling in her cheeks, lips, and tongue - "that feeling you get when you apply those lip pumping lipsticks.") and HYPOAESTHESIA ORAL (numbness in her cheeks, lips, and tongue - "that feeling you get when you apply those lip pumping lipsticks.") in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 11A21A and 047A21A) for COVID-19 vaccination. Concurrent medical conditions included Hypertension since 2008 and Prediabetes. Concomitant products included LISINOPRIL from an unknown date to 23-Mar-2021 and LOSARTAN from 24-Mar-2021 to an unknown date for Hypertension, METFORMIN for Prediabetes, ZINC, ASCORBIC ACID (VIT C), DOCOSAHEXAENOIC ACID, EICOSAPENTAENOIC ACID, TOCOPHEROL (OMEGA 3 [DOCOSAHEXAENOIC ACID;EICOSAPENTAENOIC ACID;TOCOPHEROL]), METHYL B COMPLEX and ACETYLCYSTEINE (NAC [ACETYLCYSTEINE]) for an unknown indication. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Feb-2021, the patient experienced FLUSHING (Face was flushed), PARAESTHESIA ORAL (tingling in her cheeks, lips, and tongue - "that feeling you get when you apply those lip pumping lipsticks.") and HYPOAESTHESIA ORAL (numbness in her cheeks, lips, and tongue - "that feeling you get when you apply those lip pumping lipsticks."). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at a dose of 1 dosage form. On 01-Mar-2021, FLUSHING (Face was flushed) and PARAESTHESIA ORAL (tingling in her cheeks, lips, and tongue - "that feeling you get when you apply those lip pumping lipsticks.") had resolved. At the time of the report, HYPOAESTHESIA ORAL (numbness in her cheeks, lips, and tongue - "that feeling you get when you apply those lip pumping lipsticks.") was resolving. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. This case was linked to MOD-2021-208021 (Patient Link). Reporter did not allow further contact Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: Other relevant history, treatment drugs, concomitant medications and event were added.

Other Meds: LISINOPRIL; LOSARTAN; METFORMIN; ZINC; VIT C; OMEGA 3 [DOCOSAHEXAENOIC ACID;EICOSAPENTAENOIC ACID;TOCOPHEROL]; METHYL B COMPLEX; NAC [ACETYLCYSTEINE]

Current Illness: Hypertension; Prediabetes

ID: 1559991
Sex: F
Age: 84
State: IN

Vax Date: 02/03/2021
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: arm of injection warm to touch; itchy rash of 5-6 inches high to 3-4 inches wide; arm of injection swollen; arm of injection slightly sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (arm of injection warm to touch), VACCINATION SITE RASH (itchy rash of 5-6 inches high to 3-4 inches wide), VACCINATION SITE SWELLING (arm of injection swollen) and MYALGIA (arm of injection slightly sore) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination. Concomitant products included BLOOD PRESSURE MEDICINE, MELOXICAM, VITAMINS NOS, SUPPLEMENTS and ALUMINIUM SULFATE, CALCIUM ACETATE (ASTRINGENT SOLUTION) for an unknown indication. On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (arm of injection warm to touch), VACCINATION SITE RASH (itchy rash of 5-6 inches high to 3-4 inches wide), VACCINATION SITE SWELLING (arm of injection swollen) and MYALGIA (arm of injection slightly sore). At the time of the report, VACCINATION SITE WARMTH (arm of injection warm to touch), VACCINATION SITE RASH (itchy rash of 5-6 inches high to 3-4 inches wide), VACCINATION SITE SWELLING (arm of injection swollen) and MYALGIA (arm of injection slightly sore) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. Treatment for the event included asper cream (OTC) that helps with the itch.

Other Meds: BLOOD PRESSURE MEDICINE; MELOXICAM; VITAMINS NOS; SUPPLEMENTS; ASTRINGENT SOLUTION

Current Illness:

ID: 1559992
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: kind of looks like measles; a rash between fingers and on the backs of hands; rash.. that itches; This spontaneous case was reported by an other and describes the occurrence of RASH MORBILLIFORM (kind of looks like measles), RASH (a rash between fingers and on the backs of hands) and RASH PRURITIC (rash.. that itches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH MORBILLIFORM (kind of looks like measles), RASH (a rash between fingers and on the backs of hands) and RASH PRURITIC (rash.. that itches). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and TOPICAL STEROIDS at an unspecified dose and frequency. At the time of the report, RASH MORBILLIFORM (kind of looks like measles), RASH (a rash between fingers and on the backs of hands) and RASH PRURITIC (rash. that itches) was resolving. No relevant concomitant medications were reported.

Other Meds:

Current Illness:

ID: 1559993
Sex: M
Age:
State: CT

Vax Date: 02/26/2021
Onset Date: 02/26/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Pain at the injection site) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced VACCINATION SITE PAIN (Pain at the injection site). At the time of the report, VACCINATION SITE PAIN (Pain at the injection site) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications reported. Treatment details included Ice Pack. Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1559994
Sex: F
Age: 32
State: CA

Vax Date: 01/04/2021
Onset Date: 02/10/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027L20A and 029L20A) for COVID-19 vaccination. No Medical History information was reported. On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) outcome was unknown. No relevant concomitant medications were reported. No treatment information was provided. This case was linked to MOD-2021-047108 (Patient Link). Reporter did not allow further contact

Other Meds:

Current Illness:

ID: 1559995
Sex: M
Age: 70
State: CA

Vax Date: 02/09/2021
Onset Date: 02/09/2021
Rec V Date: 08/15/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Body ache; soreness at site of injection; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body ache) and VACCINATION SITE PAIN (soreness at site of injection) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination. No Medical History information was reported. On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced MYALGIA (Body ache) and VACCINATION SITE PAIN (soreness at site of injection). At the time of the report, MYALGIA (Body ache) and VACCINATION SITE PAIN (soreness at site of injection) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No relevant concomitant medications were reported. No treatment information was provided.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 704,237

Page last modified: 26 October 2021 2:21am